Bioequivalence Study of Revolade® Eltrombopag 50 mg

NCT06834451 · clinicaltrials.gov ↗

PHASE4

Phase

ACTIVE_NOT_RECRUITING

Status

30

Enrollment

NETWORK

Sponsor class

Conditions

Healthy
Healthy Donors

Interventions

DRUG: Revolade®
DRUG: Eltrombopag (EPAG)

Sponsor

Centro de Atencion e Investigacion Medica